Episode 1: Revolutionizing Eye health Through Stemcell Research Dr. Jogin Desai Eyestem Research

Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and has built collaborations with pioneers and leaders in the space. Their long-term vision is to create a scalable cell therapy platform to treat incurable diseases and democratize access to these newer technologies for the bottom 99 % of the population globally. Eyestem has embedded manufacturing and quality processes in the platform which will enable us to create a virtuous cycle of innovation and decrease the time to market for such therapies. Their lead product out of the platform is EyecyteRPE aimed at treating Dry AMD (Age-related Macular Degeneration). Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide. Pivotal efficacy and safety studies for this product have started at Oregon Health and Science University and we expect to begin first in man studies for the same in 2022. This has been created by Atharva Marcom Public Relations. Find Atharva Marcom on the web: Find Atharva Marcom on Facebook: ...

You can listen to Episode 1: Revolutionizing Eye health Through Stemcell Research Dr. Jogin Desai Eyestem Research online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 1: Revolutionizing Eye health Through Stemcell Research Dr. Jogin Desai Eyestem Research is an episode from Health Tips' Podcast by Health Tips.

This episode is 15:29 long.

This episode was published on Jul 2, 2021.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Health Tips' Podcast when more episodes are available from the podcast feed.